HISTOPLASMA CAPSULATUM - ANVISA Registration 10259610132
Access comprehensive regulatory information for HISTOPLASMA CAPSULATUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10259610132 and manufactured by DIASORIN MOLECULAR LLC. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including IMMY INC, MIRAVISTA DIAGNOSTICS, LLC, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10259610132
25351704857201103
68814961000173
Company Information
Dates and Status
Jan 30, 2012
VIGENTE
09/18/2025 19:00:01
HISTOPLASMA CAPSULATUM
Clarus Histoplasma Galactomannan EIA
IMMY INC
81504790103
Jan 27, 2020
CRYPTOCOCCUS NEOFORMANS
Biosynex® CryptoPS
Not specified
80686360294
Aug 17, 2020
CRYPTOCOCCUS NEOFORMANS
Biosynex® CryptoPS
BIOSYNEX S.A.
80686360294
Aug 17, 2020
ASPERGILLUS SP
Dynamiker Aspergillus Galactomannan Assay
DYNAMIKER BIOTECHNOLOGY (TIANJIN) CO., LTD.
80464810606
Oct 08, 2018
CRYPTOCOCCUS NEOFORMANS
FASTLINE CRYPTOCOCCUS Ag
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
80105220179
Mar 11, 2024
HISTOPLASMA CAPSULATUM
Família de teste de LFA de antígeno urinário para histoplasma
MIRAVISTA DIAGNOSTICS, LLC
82142390001
Nov 18, 2021
HISTOPLASMA CAPSULATUM
Clarus Histoplasma Galactomannan EIA
IMMY INC
81504790103
Jan 27, 2020